Project Grant HT94252310340
Award Date
4/15/23
Completion Date
4/14/26
Dollars Obligated
$725K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK 73104, USA
Similar Awards
The University of Oklahoma received a $2,273,306 federal Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "NEUROPEPTIDE MODULATION OF CEREBRAL BLOOD FLOW TO IMPROVE NEUROLOGICAL AND PSYCHOLOGICAL OUTCOMES FOLLOWING TBI IN THE PRESENCE AND ABSENCE OF TRAUMATIC STRESS". The 4-year grant, which began on Jul 1, 2023, aims to investigate medical solutions for traumatic brain injuries (TBI) and the impacts...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
This $309,279 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research study on traumatic brain injury (TBI) and psychological health conducted by Florida State University. The primary objectives are to adapt the Ohio State University TBI Identification Method and the STAIR-NT intervention for first responders with TBI, analyze the data, and disseminate the study findings. Key sub-award activities...
The Defense Health Agency awarded a $1.5 million Project Grant to the Western Institute For Veterans Research to support the POSITIONED (PRECISION, STANDARDIZATION AND ORGANIZATIONAL READINESS IN TBI CARE) program. This funding will support the Military Medical Research and Development program's goal of transforming health care for Service Members and the public through innovative medical research solutions for the battlefield. Specifically, the POSITIONED program will conduct research from...
The University of Arizona, through the Arizona Board of Regents, was awarded a $3,004,651 Project Grant from the Defense Health Agency to develop a treatment for neuropsychological and memory impairments following moderate to severe traumatic brain injury. This grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, funds a research project aimed at advancing scientific understanding and improving patient care for service members and veterans affected by...
This $3,150,000 Project Grant award from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) will fund a randomized clinical trial using noninvasive brain stimulation combined with written exposure therapy for post-traumatic stress disorder (PTSD) in military personnel with mild traumatic brain injury. The award was granted to The University of Texas Health Science Center at San Antonio, a Hispanic-serving academic medical institution with extensive...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
The Defense Health Agency awarded a $1,973,398 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Azevan Pharmaceuticals Inc. in Bethlehem, PA. The grant supports the development of a new drug to prevent the effects of mild traumatic brain injury (TBI) or concussion. The research project will be conducted over a 2-year period from June 2024 to June 2026. The goal is to advance the development of an innovative medical solution to address this critical...
The Department of the Army Medical Command awarded a $1,302,658 Project Grant to the RU School of Osteopathic Medicine through the Military Medical Research and Development program. This three-year award will fund research into the effects of psychostimulants on cognitive flexibility and risk-based decision-making behavior following repetitive mild traumatic brain injury. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research aimed at...
The Department of the Army Medical Command awarded a $1.66 million Project Grant to the University of Utah's Office of Sponsored Projects under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research into "Spreading Depolarizations' in the Network Dysfunction Leading to Post-Traumatic Headache." Through September 2021 to August 2024, the grantee will investigate medical solutions for post-traumatic headache on the battlefield and...